BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis
NASDAQ:BWAY - Nasdaq - US10501L1061 - ADR - Currency: USD
Overall BWAY gets a fundamental rating of 6 out of 10. We evaluated BWAY against 187 industry peers in the Health Care Equipment & Supplies industry. BWAY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. An interesting combination arises when we look at growth and value: BWAY is growing strongly while it also seems undervalued. These ratings would make BWAY suitable for value and growth investing!
1. Profitability
1.1 Basic Checks
In the past year BWAY was profitable.
BWAY had a positive operating cash flow in the past year.
BWAY had negative earnings in 4 of the past 5 years.
In multiple years BWAY reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.91%, BWAY belongs to the top of the industry, outperforming 80.75% of the companies in the same industry.
BWAY's Return On Equity of 6.14% is amongst the best of the industry. BWAY outperforms 81.28% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.90%, BWAY is in the better half of the industry, outperforming 68.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.91% | ||
| ROE | 6.14% | ||
| ROIC | 1.9% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 9.01%, BWAY belongs to the best of the industry, outperforming 82.89% of the companies in the same industry.
Looking at the Operating Margin, with a value of 4.32%, BWAY is in the better half of the industry, outperforming 70.05% of the companies in the same industry.
The Gross Margin of BWAY (74.51%) is better than 87.70% of its industry peers.
BWAY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.32% | ||
| PM (TTM) | 9.01% | ||
| GM | 74.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWAY is destroying value.
BWAY has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BWAY has more shares outstanding
The debt/assets ratio for BWAY is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.12 indicates that BWAY is not in any danger for bankruptcy at the moment.
BWAY has a better Altman-Z score (4.12) than 73.80% of its industry peers.
The Debt to FCF ratio of BWAY is 0.69, which is an excellent value as it means it would take BWAY, only 0.69 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BWAY (0.69) is better than 92.51% of its industry peers.
BWAY has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.07, BWAY is doing good in the industry, outperforming 61.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.69 | ||
| Altman-Z | 4.12 |
ROIC/WACC0.21
WACC9%
2.3 Liquidity
A Current Ratio of 5.03 indicates that BWAY has no problem at all paying its short term obligations.
BWAY has a better Current ratio (5.03) than 74.87% of its industry peers.
A Quick Ratio of 4.75 indicates that BWAY has no problem at all paying its short term obligations.
BWAY's Quick ratio of 4.75 is fine compared to the rest of the industry. BWAY outperforms 78.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.03 | ||
| Quick Ratio | 4.75 |
3. Growth
3.1 Past
BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 268.04%, which is quite impressive.
Looking at the last year, BWAY shows a very strong growth in Revenue. The Revenue has grown by 26.86%.
The Revenue has been growing by 12.17% on average over the past years. This is quite good.
EPS 1Y (TTM)268.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)26.86%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%25.07%
3.2 Future
The Earnings Per Share is expected to grow by 23.62% on average over the next years. This is a very strong growth
BWAY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.51% yearly.
EPS Next Y32.06%
EPS Next 2Y23.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.2%
Revenue Next 2Y20.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 12.18, the valuation of BWAY can be described as correct.
BWAY's Price/Earnings ratio is rather cheap when compared to the industry. BWAY is cheaper than 91.44% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.98. BWAY is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 9.92, the valuation of BWAY can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BWAY indicates a rather cheap valuation: BWAY is cheaper than 93.58% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.49, BWAY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.18 | ||
| Fwd PE | 9.92 |
4.2 Price Multiples
BWAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BWAY is cheaper than 67.38% of the companies in the same industry.
BWAY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BWAY is cheaper than 81.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31 | ||
| EV/EBITDA | 49.32 |
4.3 Compensation for Growth
BWAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BWAY's earnings are expected to grow with 23.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y23.62%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for BWAY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BWAY (6/30/2025, 4:04:06 PM)
13.15
-0.07 (-0.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners5.19%
Inst Owner Change1.22%
Ins Owners16.69%
Ins Owner ChangeN/A
Market Cap248.32M
Analysts85.71
Price Target0.08 (-99.39%)
Short Float %0.66%
Short Ratio2.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)35.29%
Min EPS beat(2)-22.64%
Max EPS beat(2)93.23%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)0.01%
Revenue beat(4)3
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.82%
Revenue beat(8)6
Avg Revenue beat(8)1.7%
Revenue beat(12)6
Avg Revenue beat(12)-23.98%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.45%
PT rev (3m)-0.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.06%
EPS NY rev (1m)0%
EPS NY rev (3m)65.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.18 | ||
| Fwd PE | 9.92 | ||
| P/S | 5.71 | ||
| P/FCF | 31 | ||
| P/OCF | 20.47 | ||
| P/B | 3.9 | ||
| P/tB | 3.9 | ||
| EV/EBITDA | 49.32 |
EPS(TTM)1.08
EY8.21%
EPS(NY)1.33
Fwd EY10.08%
FCF(TTM)0.42
FCFY3.23%
OCF(TTM)0.64
OCFY4.88%
SpS2.3
BVpS3.38
TBVpS3.38
PEG (NY)0.38
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.91% | ||
| ROE | 6.14% | ||
| ROCE | 2.25% | ||
| ROIC | 1.9% | ||
| ROICexc | 13.5% | ||
| ROICexgc | 13.5% | ||
| OM | 4.32% | ||
| PM (TTM) | 9.01% | ||
| GM | 74.51% | ||
| FCFM | 18.43% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.69 | ||
| Debt/EBITDA | 1.28 | ||
| Cap/Depr | 223.14% | ||
| Cap/Sales | 9.47% | ||
| Interest Coverage | 8.86 | ||
| Cash Conversion | 325.76% | ||
| Profit Quality | 204.52% | ||
| Current Ratio | 5.03 | ||
| Quick Ratio | 4.75 | ||
| Altman-Z | 4.12 |
F-Score6
WACC9%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)268.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y32.06%
EPS Next 2Y23.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.86%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%25.07%
Revenue Next Year19.2%
Revenue Next 2Y20.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y256.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y217.63%
OCF growth 3Y127.03%
OCF growth 5YN/A